SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020191
Filing Date
2021-04-23
Accepted
2021-04-23 06:02:06
Documents
6
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A cnst-def14a_20210602.htm DEF 14A 1411445
2 GRAPHIC gh3siczwullc000001.jpg GRAPHIC 3981
3 GRAPHIC gh3siczwullc000002.jpg GRAPHIC 5760
4 GRAPHIC gh3siczwullc000003.jpg GRAPHIC 3981
5 GRAPHIC gh3siczwullc000004.jpg GRAPHIC 59350
6 GRAPHIC gh3siczwullc000005.jpg GRAPHIC 47121
  Complete submission text file 0001564590-21-020191.txt   1578745
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38584 | Film No.: 21846578
SIC: 2834 Pharmaceutical Preparations